NIMBEX INJECTION 2mg/ML

Product Information

Registration Status: Active

NIMBEX INJECTION 2mg/ML is approved to be sold in Singapore with effective from 2013-05-02. It is marketed by DCH AURIGA SINGAPORE, with the registration number of SIN14309P.

This product contains Cisatracuriuml 2mg/ml in the form of INJECTION, SOLUTION. It is approved for INTRAVENOUS use.

This product is manufactured by GlaxoSmithKline Manufacturing S.p.A. in ITALY.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Cisatracuriuml


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank